Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Wednesday preview: Nvidia, US debt auction in focus

(Sharecast News) - Investors' focus in the middle of the week will be on US chip-making giant Nvidia, which is due to release its second quarter results after the New York close.

They will arrive with shares in the more than $4trn market-cap firm trading just off their record highs.

Management's guidance for the latest quarter was for revenues of $45bn +/-2%, while gross margins are expected to improve to 72%.

As City analyst Michael Hewson notes, incorporated into that guidance were new US restrictions on sales of chips overseas, which were expected to subtract around $8bn from the topline.

The session is otherwise expected to be on the quiet side with an auction of five-year US Treasuries at 1700 BST arguably the most important event on the economic calendar.

In Germany meanwhile, consultancy GfK will publish the results of its consumer confidence survey for September.

No major economic reports are scheduled for release in the UK.

Wednesday 27 August

INTERIMS

Sydbank A/S Sydbank Ord Shs

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Crude Oil Inventories (US) (15:30)

GFK Consumer Confidence (GER) (07:00)

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.